News
The deal disrupts a long-established practice of the exemption of medicines from tariffs due to their importance in public ...
England has launched a world-first gonorrhoea vaccination programme that will potentially help avert up to 100,000 cases of the disease and save millions of NHS funding.
The US has imposed a steep 25 per cent tariff on Indian goods, targeting key export sectors like textiles, diamonds, and auto ...
Mumbai: Aurobindo Pharma Ltd has posted a 10.2 percent year-on-year (YoY) decline in consolidated net profit for the first ...
The Gates Foundation has announced an investment of $2.5bn to 2030, dedicated to expediting R&D with a focus on improving women's health.
Considering the bioequivalence study results of the MSN Labs Cenobamate Tablets 12.5 mg, 25 mg, 50mg, 100 mg, 150 mg & 200 mg ...
ING's Diederik Stadig on how the latest tariff developments could impact both consumers and the pharmaceutical industry ...
India’s pharmaceutical landscape is undergoing a vital transformation. Despite being home to one of the world’s largest ...
On his part, Madbouly emphasized that this meeting aims to follow up on efforts to advance the pharmaceutical industry ...
Stealth BioTherapeutics, which has been developing a rare disease drug, said it is making contingency plans to close the ...
Phebra is deeply saddened to announce the passing of its Founder and former Chief Executive Officer, Dr Mal Eutick OAM, who died in Sydney on Sunday 3 ...
Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 2990 in its research report dated August 01, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results